Gel Boosts Stem Cell Studies
News Jan 10, 2013
Scientists have developed a family of compounds that can support the growth of human embryonic stem cells on a large scale.
Their technique could have applications for use in drug testing or treatments for conditions such as such as Huntington’s and Parkinson’s diseases.
The new materials, which are water-based gels, act as a tiny scaffold to which cells can cling as they grow.
Normally cells must be grown on expensive biological surfaces that can carry risk of contamination.
Once cells have multiplied sufficiently for their intended purpose, the gels can be cooled, enabling the stem cells to drop off the scaffold without becoming damaged.
The new approach surpasses existing techniques of separating cells by mechanical or chemical means, which carry a greater risk of damage to cells.
Scientists say the materials could offer a means of enabling the stem cells to be produced in large numbers efficiently and with a lowered risk of contamination.
This could facilitate research, drug screening programmes and clinical applications that call for large numbers of cells.
Researchers at the University developed the materials by screening hundreds of potential compounds for their ability to support stem cell growth.
From a shortlist of four, one has been found to be effective, and researchers say the remaining three show similar potential.
Stem cells provide a powerful tool for screening drugs as they can be used to show the effects of drugs on cells and systems within the body.
The study, published in Nature Communications, was supported by the European Union Framework 7 Grant Funding.
The gels are being developed under licence by technology company Ilika.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Targeting a Leaky Protein that Causes ParalysisNews
A rare genetic disorder in which people are overcome suddenly with profound muscle weakness is caused by a hole in a membrane protein that allows sodium ions to leak across cell membranes. Compounds containing a chemical group called guanidinium can block the pore created by the mutation and stop the sodium leak without altering the voltage sensor’s ability to function.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018